RxDoctor Payments Data

Justin Duke, MD

Orthopaedic Surgery · Natchitoches, LANPI 1710148085

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Think Surgical, Inc. accounts for 69.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $10,503 and has fallen 77.9% since, to $2,316 in 2025.

$17,146in general payments, 2019–2025

Across 70 payments — averaging $244.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Think Surgical, Inc.$12K
  • Zimmer Biomet$2K
  • Stryker$860
  • Johnson & Johnson$518
  • Medical Device Business Services, Inc.$398
  • Brainlab, Inc.$328
  • plus $773 from 11 others

What the payments were for

  • Consulting fees$10,00058%
  • Travel & lodging$3,17319%
  • Food & beverage$3,92723%
  • Education$470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,146 in reported general payments places this provider in the 80th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$75,772
Medicare patients
506
Services billed
1,692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib14$239
Oxycodone Hcl41$202
Methylprednisolone11$82
Tramadol Hcl14$52

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Natchitoches

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →